9 Meters Biopharma, Inc. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/44a9bc73-a3bd-4faf-9f16-1b405a8cdacf/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-42.0M | 2022-01-01 – 2022-12-31 | evidence 0001551986-23-000021 |
| FY 2021 | $-36.8M | 2021-01-01 – 2021-12-31 | evidence 0001551986-22-000030 |
| FY 2020 | $-60.9M | 2020-01-01 – 2020-12-31 | evidence 0001551986-21-000033 |
| FY 2019 | $-25.5M | 2019-01-01 – 2019-12-31 | evidence 0001551986-21-000033 |
| FY 2018 | $18.2M | 2018-01-01 – 2018-12-31 | evidence 0001551986-19-000019 |
| FY 2017 | $11.2M | 2017-01-01 – 2017-12-31 | evidence 0001551986-19-000019 |
| FY 2016 | $-5.9M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017815 |
| FY 2015 | $-6.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-017815 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).